Europe: Klebsiella pneumoniae drug resistance reported among travelers to the Canary Islands



[ad_1]

A group of European travelers returning from the island of Gran Canaria reportedly carried or would have been infected with Klebsiella pneumoniae ST392, a carbapenemase (OXA-48), according to the rapid risk assessment of the country. ECDC published last week.

  Klebsiella pneumoniae / CDC
Klebsiella pneumoniae / CDC

The group included 13 individuals from Sweden, Finland and Norway and is an example of cross-border spread of carbapenemase-producing enterobacteria (ECP) in the European Union / European Economic Area (EU / EEA)

Six Swedish cases notified between January and April 2018 were all hospitalized in the same hospital in Gran Canaria, while three of the Norwegian travelers were hospitalized in the same hospital. hospital as Swedish travelers.

ECDC Cross-border patient transfers or hospital admissions of patients hospitalized in another country are common in EU / EEA hospitals

. According to the authorities, the acquisition of K. pneumoniae ST392 of the Gran Canaria group producing OXA-48 without contact with health care is very small. However, if K. pneumoniae ST392 carriers of the Gran Canaria bunch producing OXA-48 are admitted to a hospital in their country of origin, the risk of transmission and subsequent outbreaks are high if K pneumoniae ST392 produces OXA-48. transport remains undetected and there are no adequate infection control and prevention measures.

Read more at ECDC

[ad_2]
Source link